🌅 Beyond the Belly: Ozempic May Have Mental Health Benefits

SOURCE

Taipale et al. (2026)

WHAT TO KNOW

• A new study by researchers at the University of Eastern Finland found GLP-1 medications like Ozempic are strongly associated with significant mental health benefits, including a 44% lower risk of depression and 38% lower risk of anxiety disorders. The study also found GLP-1 use was associated with notable decreases in substance use disorders, mental health-related hospital visits, and the risk of suicidal behavior. The researchers analyzed data from 95,000 individuals, including 20,000 who used GLP-1 medications. The study was published in The Lancet Psychiatry.

WHY IT MATTERS

• The researchers believe the improved mental health outcomes could stem from the known downstream effects on mood and anxiety associated with reduced alcohol consumption, improved body image, and the relief associated with better glycemic control in diabetes. However, it’s also possible there could be direct neurobiological mechanisms involved, like changes in the functioning of the brain’s reward system. The authors say more work is needed to determine whether a causal relationship—as opposed to only an association—between GLP-1 use and improved mental health outcomes actually exists.

CONNECT THE DOTS

• About 1 in 8 U.S. adults (12%) report using a GLP-1 medication like Ozempic, a 6 percentage point increase from 2024. Other data suggests GLP-1s could help reduce alcohol use disorder and improve heart health. However, experts say more work is needed to understand the biological mechanisms underpinning any associated benefits. Further, other research shows GLP-1 use may increase the risk of pancreatic cancer for certain patients and is linked to an elevated risk of preterm births among pregnant women.